OTCPicks.com Stocks to Watch for Wednesday, March 12th PMED, CEEH, QEDC, NRGN, CYTO, AIXD

OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets.  In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.

Our Stocks to Watch tomorrow include Paradigm Medical Industries, Inc. (OTCBB: PMED), Chanticleer Holdings, Inc. (OTCBB: CEEH), QED Connect, Inc. (OTC: QEDC), Neurogen Corporation (NASDAQ: NRGN), Cytogen Corporation (NASDAQ: CYTO) and Access Integrated Technologies (NASDAQ: AIXD).

For the complete newsletter please visit: http://www.otcpicks.com/stocks-to-watch/index.php

For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/

PARADIGM MEDICAL INDUSTRIES (OTCBB: PMED)

"Up 57.14% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/PMED.php

Paradigm Medical Industries, Inc. engages in the design, development, manufacture, and sale of technology surgical and diagnostic eye care products. Its diagnostic products include P55, P2200, and P2500 pachymetric analyzer; P20 and P2000 A-scan biometric ultrasound analyzer; P37, P37-II, and P2700 A/B scan ocular ultrasound diagnostic product; P40 UBM ultrasound biomicroscope; P45 UBM ultrasound biomicroscope; P60 UBM ultrasound biomicroscope; BFA ocular blood flow analyzer and disposables; CT 200 corneal topography system; LD 400 autoperimetry system; and TKS 5000 autoperimetry system. The company's products also comprise Precisionist Thirty Thousand and Photon laser, which have ocular surgery workstation with surgical equipment and disposables. Paradigm's surgical products are systems for use by ophthalmologists to perform surgical treatment procedures to remove cataracts. It markets its products through direct sales representatives, independent sales representatives, and ophthalmic product distributors in the United States, as well as through a network of dealers internationally. The company was founded in 1989 and is based in Salt Lake City, Utah.

CHANTICLEER HOLDINGS (OTCBB: CEEH)

"Up 45.45% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/CEEH.php

Chanticleer Holdings, Inc., a business development company, specializes in investing in undervalued small/micro-cap companies. The firm's investment approach is based on the philosophies and strategies of investors, such as Warren Buffett, Benjamin Graham, and Philip Fisher. It aims to manage a low-turnover portfolio of equities while developing a non-operational relationship with those companies and their management. Chanticleer Holdings began operations in June 2005 and is based in Charlotte, North Carolina.

QED CONNECT INCORPORATED (OTC: QEDC)

"Up 37.50% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/QEDC.php

QED Connect, Inc. is an information security Software-as-a-Service (SaaS) provider that gives organizations visibility, management and control of activity on all their computers, laptops and wireless devices. The company's popular SaaS, Omni Manager, is an affordable way to monitor and manage how employees are using company computers and the Internet at any time, from any location in the world. This solves the problems created by today's 'virtual' work environment of branch offices, remote workers and traveling employees. Omni Manager is a web-hosted software application that includes e-mail and Internet filtering and blocking, antivirus, instant messaging management, asset tracking, application usage monitoring and policy management. ROI is delivered by employee productivity gains, cost savings and improved operational efficiencies. For more information, visit http://www.qedconnect.com/.

NEUROGEN CORPORATION (NASD: NRGN)

"Up 21.23% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/NRGN.php

Neurogen Corporation operates as a drug discovery and development company focusing on new small molecule drugs for various disorders, including insomnia, obesity, pain, Parkinson's disease, Restless Legs Syndrome (RLS), and depression/anxiety. Its clinical development programs include NG2-73, which is in phase II clinical trials for the treatment of insomnia; NGD-8243/MK2295, a vanilloid receptor (VR1) antagonist, which is in phase II clinical trials for treating pain; Aplindore, a small molecule partial agonist for the D2 dopamine receptor for the treatment of Parkinson's disease and RLS; and NGD-4715, which is in phase I clinical trial for the treatment of obesity. The company has collaboration agreement with Merck & Co., Inc. to discover and develop drugs targeting VR1 for the treatment of pain. Neurogen was founded in 1987 and is based in Branford, Connecticut.

CYTOGEN CORPORATION (NASD: CYTO)

"Up 26.09% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/CYTO.php

Cytogen Corporation, a biopharmaceutical company, builds, develops, and commercializes a portfolio of specialty pharmaceutical products for the treatment and care of cancer patients. It markets QUADRAMET (samarium Sm-153 lexidronam injection), PROSTASCINT (capromab pendetide), and SOLTAMOX (tamoxifen citrate) to the United States oncology market. QUADRAMET is approved for the treatment of pain in patients whose cancer has spread to the bone, PROSTASCINT is a prostate-specific membrane antigen (PSMA)-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer, and SOLTAMOX is the liquid hormonal therapy approved in the U.S. for the treatment of breast cancer in adjuvant and metastatic settings. The company intends to introduce its fourth approved oncology product, CAPHOSOL, an advanced electrolyte solution for the treatment of oral mucositis and dry mouth. CAPHOSOL is approved in the U.S. as a prescription medical device. It is also developing CYT-500, a third-generation radiolabeled antibody to treat prostate cancer. The company was founded in 1980. It was formerly known as Hybridex, Inc. and subsequently changed its name to Cytogen Corporation. Cytogen Corporation is headquartered in Princeton, New Jersey.

ACCESS INTEGR TECHNOLOGIES (NASD: AIXD)

"Up 16.80% on Tuesday"

Detailed Quote: http://www.otcpicks.com/quotes/AIXD.php

Access Integrated Technologies, Inc. (AccessIT) provides integrated solutions for digital cinema in the United States. It offers software and services that enable the motion picture entertainment industry and its constituents to transit from film to digital cinema. The company provides three key integrated solutions: management software and services for distributors and exhibitors; managed electronic delivery of movies and other content using satellite or fiber interchangeably; and vendor agnostic in-theatre application software to serve as the single point of operations and storage for the P.O.S., projection systems, and content in a multiplex. The company's digital cinema networked services along with its Library Management Server and Theatre Command Center enables theatres across the United States to play digital 2-D and 3-D showings of Hollywood features. AccessIT's vendor neutral solutions provide pre-show entertainment, feature movies, and live and pre-recorded alternative content via satellite to expand box office sales. Through its alternative content distribution division, The Bigger Picture, it offers channels of programming, including Kidtoons, Faith Based, Music, High Octane Sports, and Anime. The company was founded in 2000 and is headquartered in Morristown, New Jersey.

OTCPicks.com Daily Volume Leaders – Microsoft (Nasdaq: MSFT), Applied Materials (Nasdaq: AMAT), Level 3 Communications (Nasdaq: LVLT), Dell Inc (Nasdaq: DELL), Apple Inc. (Nasdaq: AAPL), and Research in Motion (Nasdaq: RIMM)

About OTCPicks.com

OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor.  The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.